| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 88.393 | 88.584 | 88.467 | 85.464 | 199.521 | 166.904 | 128.761 | 89.349 | 100.628 | 106.702 |
| Total Income - EUR | 99.271 | 88.584 | 88.467 | 85.464 | 199.521 | 166.904 | 128.761 | 89.632 | 100.628 | 106.702 |
| Total Expenses - EUR | 88.244 | 63.775 | 51.077 | 50.364 | 174.799 | 117.683 | 58.888 | 18.846 | 40.582 | 83.339 |
| Gross Profit/Loss - EUR | 11.027 | 24.809 | 37.390 | 35.100 | 24.722 | 49.220 | 69.873 | 70.786 | 60.046 | 23.363 |
| Net Profit/Loss - EUR | 10.018 | 20.839 | 36.001 | 34.239 | 22.302 | 47.543 | 68.585 | 70.025 | 59.090 | 21.496 |
| Employees | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 3 | 6 |
Check the financial reports for the company - Farmacy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 93.085 | 95.297 | 141.836 | 194.031 | 170.088 | 153.829 | 157.823 | 419.322 | 441.034 | 453.944 |
| Current Assets | 161.589 | 156.229 | 175.719 | 206.876 | 241.799 | 265.143 | 330.255 | 379.805 | 377.630 | 354.878 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 909 | 3.068 |
| Receivables | 161.397 | 156.198 | 175.708 | 206.089 | 241.789 | 265.095 | 324.985 | 362.804 | 363.317 | 343.300 |
| Cash | 191 | 31 | 11 | 787 | 10 | 48 | 5.270 | 17.001 | 13.404 | 8.510 |
| Shareholders Funds | 155.734 | 164.267 | 234.530 | 289.151 | 270.377 | 263.309 | 326.055 | 397.091 | 485.856 | 504.637 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 95.108 | 106.964 | 113.290 | 112.249 | 137.494 | 151.724 | 157.017 | 397.014 | 328.242 | 299.644 |
| Income in Advance | 5.571 | 5.515 | 5.421 | 5.322 | 5.219 | 5.120 | 5.006 | 5.022 | 5.007 | 4.979 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6832 - 6832" | |||||||||
| CAEN Financial Year |
6832
|
|||||||||
Comments - Farmacy Srl